Inogen | INGN - Operating Expenses


Inogen reported $49.14M in Operating Expenses for its fiscal quarter ending in September of 2024.





Operating Expenses Change Date
Abbott USD 9.21B 17M Dec/2025
AngioDynamics USD 81.98M 1.96M Feb/2025
AtriCure USD 134.06M 8.27M Sep/2025
Baxter International USD 2.63B 95.8M Sep/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
Chart Industries USD 923.1M 10.3M Sep/2025
Cooper Companies USD 924.8M 40.2M Sep/2025
Dexcom USD 966.8M 22.3M Sep/2025
Edwards Lifesciences USD 1.2B 71.3M Dec/2025
Globus Medical USD 886.57M 730.06M Sep/2025
Inogen USD 49.14M 665K Sep/2024
Insulet USD 588.6M 60.6M Sep/2025
Masimo USD 147M 159.4M Sep/2025
Medtronic USD 7.26B 283M Sep/2025
Orthofix International USD 10.89M 209.57M Sep/2024
Philips EUR 4.38B 405M Dec/2025
ResMed USD 925.21M 51.98M Dec/2025
Steris USD 1.22B 28.8M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 272.12M 421K Sep/2025
Teleflex USD 3.82B 3.22B Sep/2025
X T L Biopharmaceuticals USD 1.1M 175K Dec/2024
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025